431 Results

People

  1. Motzer
    Motzer
  2. Voss
    Voss
  3. Feldman
    Feldman
  4. Antonescu
    Antonescu
  5. Hakimi
    Hakimi
  6. Patil
    Patil
  7. Abou-Alfa
    Abou-Alfa
  8. DeMatteo
    DeMatteo
  9. Ginsberg
    Ginsberg
  10. Reidy
    Reidy

Groups

  1. Department of Medicine (315)
  2. Solid Tumor Oncology Division (288)
  3. Genitourinary Oncology Service (198)
  4. Surgery (60)
  5. GSK Faculty (47)
  6. Department of Pathology and Laboratory Medicine (44)
  7. Gastrointestinal Oncology Service (41)
  8. Radiology, Department of (38)
  9. Survivorship Research (34)
  10. Tow Center for Developmental Oncology (TCDO) (33)
  1. "sunitinib"
Formats
  1. Journal Article (391)
  2. Review (21)
  3. Editorial (5)
  4. Research Letter (4)
  5. Book Section (3)
  6. Correspondence (3)
  7. Guidelines (3)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (315)
  2. Solid Tumor Oncology Division (288)
  3. Genitourinary Oncology Service (198)
  4. Surgery (60)
  5. GSK Faculty (47)
  6. Department of Pathology and Laboratory Medicine (44)

More Groups

People
  1. Robert Motzer (159)
  2. Martin Voss (24)
  3. Darren Feldman (23)
  4. Robert Maki (20)
  5. Chung-Han Lee (17)
  6. Cristina Antonescu (17)

More People

Years
  1. 2025 (7)
  2. 2024 (18)
  3. 2023 (18)
  4. 2022 (18)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Journal of Clinical Oncology (19)
  2. Clinical Cancer Research (18)
  3. European Urology (18)
  4. Journal of the National Comprehensive Cancer Network (17)
  5. Cancer (14)
  6. European Journal of Cancer (13)

More Publications

Publishers
  1. Elsevier Inc. (69)
  2. Elsevier Science, Inc. (38)
  3. Springer (31)
  4. Wiley Blackwell (30)
  5. Oxford University Press (29)
  6. Nature Publishing Group (27)

More Publishers

Results (431)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: A cohort study
    Journal Article

    Sanchez, A.; Furberg, H.; Kuo, F.; Vuong, L.; Ged, Y.; Patil, S.; Ostrovnaya, I.; Petruzella, S.; Reising, A.; Patel, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Progress toward precision medicine in frontline treatment of metastatic renal cell carcinoma
    Editorial

    Singla, N.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Metachronous renal cell carcinoma with metastasis to the urinary bladder, and distant organs, 28 years after radical nephrectomy: A case report
    Journal Article

    Babar, M.; Hamdani, S.; Liu, C.; Vedula, J.; Schnapp, D. S.
    BMC Urology (2019)

    Fulltext@MSK | Save
  • Systemic therapies for metastatic pancreatic neuroendocrine tumors
    Review

    Hauser, H.; Gerson, D. S.; Reidy-Lagunes, D.; Raj, N.
    Current Treatment Options in Oncology (2019)

    Fulltext@MSK | Save
  • Cabozantinib versus sunitinib for untreated patients with advanced renal cell carcinoma of intermediate or poor risk: Subgroup analysis of the Alliance A031203 CABOSUN trial
    Journal Article

    George, D. J.; Hessel, C.; Halabi, S.; Michaelson, M. D.; Hahn, O.; Walsh, M.; Picus, J.; Small, E. J.; Dakhil, S.; Feldman, D. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • COMPARZ post hoc analysis: Characterizing pazopanib responders with advanced renal cell carcinoma
    Journal Article

    Sternberg, C. N.; Motzer, R. J.; Hutson, T. E.; Choueiri, T. K.; Kollmannsberger, C.; Bjarnason, G. A.; Paul, Nathan; Porta, C.; Grünwald, V.; Dezzani, L.; more...
    Clinical Genitourinary Cancer (2019)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: Extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
    Journal Article

    Motzer, R. J.; Rini, B. I.; McDermott, D. F.; Arén Frontera, O.; Hammers, H. J.; Carducci, M. A.; Salman, P.; Escudier, B.; Beuselinck, B.; Amin, A.; more...
    Lancet Oncology (2019)

    Fulltext@MSK | Save
  • PD-L1 expression and clinical outcomes to cabozantinib, everolimus, and sunitinib in patients with metastatic renal cell carcinoma: Analysis of the randomized clinical trials METEOR and CABOSUN
    Journal Article

    Flaifel, A.; Xie, W.; Braun, D. A.; Ficial, M.; Bakouny, Z.; Nassar, A. H.; Jennings, R. B.; Escudier, B.; George, D. J.; Motzer, R. J.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Tumor microenvironment dynamics in clear-cell renal cell carcinoma
    Review

    Vuong, L.; Kotecha, R. R.; Voss, M. H.; Hakimi, A. A.
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Bleeding disorders associated with cancer
    Journal Article

    Mantha, S.
    Cancer Treatment and Research (2019)

    Fulltext@MSK | Save